The Cell Culture Dish (CCD) podcast covers areas important to the research, discovery, development, and manufacture of disease and biologic therapeutics. Key industry coverage areas include: drug discovery and development, stem cell research, cell and gen
Dr. Paul Wotton, CEO, talks about Sigilon Therapeutics’ discovery platform. The platform combines cell engineering and biocompatible Afibromer™ technology...
Alyssa Master, Ph.D., Senior Manager of Science and Applications, Nucleus Biologics talks about some of the challenges of working with FBS, why not...
Dr. Adam Elhofy, Ph.D., Chief Scientific Officer, Bio-Ess Laboratories, talks about the relationship between antibody titer and product quality attributes...